Immune Globulin Subcutaneous (Human) 20%: In Primary Immunodeficiency Disorders

By McCormack Paul L.  

Drugs, Vol. 72, Iss. 8, 2012-05 ,pp. : 1087-1097

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Darbepoetin Alfa after Intravenous or Subcutaneous Administration in Patients with Non-myeloid Malignancies Undergoing Chemotherapy

By Heatherington Anne C.  

Clinical Pharmacokinetics, Vol. 45, Iss. 2, 2006-01 ,pp. : 199-211

Adis International

Access to resources Recommend Favorite

Population pharmacokinetics of darbepoetin alfa in peritoneal dialysis and non-dialysis patients with chronic kidney disease after single subcutaneous administration

By Kawakami Kazuki   Takama Hirotaka   Nakashima Daisuke   Tanaka Hideji   Uchida Eiji   Akizawa Tadao  

European Journal of Clinical Pharmacology, Vol. 65, Iss. 2, 2009-02 ,pp. : 169-178

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics of methadone in human-immunodeficiency-virus-infected patients receiving nevirapine once daily

By Arroyo Elena   Valenzuela Belén   Portilla Joaquín   Climent-Grana Eduardo   Pérez-Ruixo Juan   Merino Esperanza  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 7, 2007-07 ,pp. : 669-675

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics of Melagatran and the Effect on Ex Vivo Coagulation Time in Orthopaedic Surgery Patients Receiving Subcutaneous Melagatran and Oral Ximelagatran: A Population Model Analysis

By Eriksson Ulf G.  

Clinical Pharmacokinetics, Vol. 42, Iss. 7, 2003-01 ,pp. : 687-701

Adis International

Access to resources Recommend Favorite